Showing results (1321-1330 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|September 12, 2014
Long-term outcomes from dose-escalated image-guided intensity-modulated radiotherapy with androgen deprivation: encouraging results for intermediate- and high-risk prostate cancerShea W Wilcox, Noel J Aherne, Linus C Benjamin, et al.Oncotargets and Therapy|August 15, 2014
Silencing B7-H1 enhances the anti-tumor effect of bladder cancer antigen-loaded dendritic cell vaccine in vitroShuo Wang, Yonghua Wang, Jing Liu, et al.Oncotargets and Therapy|November 25, 2014
Efficient utilization of EBUS-TBNA samples for both diagnosis and molecular analysesF Oezkan, Am Khan, P Zarogoulidis, et al.Oncotargets and Therapy|November 5, 2014
Downregulated Ku70 and ATM associated to poor prognosis in colorectal cancer among Chinese patientsYuanfang Lu, Jingyan Gao, Yuanming LuOncotargets and Therapy|November 4, 2014
Metronomic capecitabine in gastroenteropancreatic neuroendrocrine tumors: a suitable regimen and review of the literatureAlberto Bongiovanni, Nada Riva, Sebastiano Calpona, et al.Oncotargets and Therapy|November 4, 2014
Angiopoietin 2 as a therapeutic target in hepatocellular carcinoma treatment: current perspectivesManojkumar Bupathi, Ahmed Kaseb, Filip JankuOncotargets and Therapy|November 8, 2014
More than 9 years of continuous trastuzumab treatment in metastatic breast cancer without cardiac toxicity: a case report and literature reviewFlorin Badulescu, Adriana Badulescu, Doru Paul, et al.Oncotargets and Therapy|November 8, 2014
Ramucirumab: preclinical research and clinical developmentGiuseppe Aprile, Erika Rijavec, Caterina Fontanella, et al.Oncotargets and Therapy|November 8, 2014
The effects of ponatinib, a multi-targeted tyrosine kinase inhibitor, against human U87 malignant glioblastoma cellsJunxia Zhang, Qiang Zhou, Ge Gao, et al.Oncotargets and Therapy|November 11, 2014
Prognostic significance of CDH13 hypermethylation and mRNA in NSCLCRuilin Xue, Cuili Yang, Fang Zhao, et al.Pageof 672